Table 1. Characteristics of participants.

Variables		Values
Total, No.		88
Male		57 (65)
Age (yr)		11.5 (10.4–13.7)
Complications	AD	46 (52)
	AR	61 (69)
	AC	42 (48)
ACT* score		25 (24–25)
C-ACT† score		26 (24–27)
Treatment	ICS	69 (78)
	Leukotriene receptor antagonist	26 (30)
	Dose of ICS (µg/day, fluticasone equivalent)	100 (100–200)
FVC (% pred.)		97 (89–105)
FEV1 (% pred.)		96 (85–102)
FEV1/FVC (% pred.)		86.8 (83.7–89.6)
$\dot{\text{V}}$50 (% pred.)		85 (70–103)
$\dot{\text{V}}$25 (% pred.)		80 (61–92)

Values are presented as number (%) or median (quartile).

AD, atopic dermatitis; AR, allergic rhinitis; AC, allergic conjunctivitis; ACT, Asthma Control Test; C-ACT, Childhood Asthma Control Test; ICS, inhaled corticosteroid; % pred., % of predicted value; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; $\dot{\text{V}}$₅₀, flow at 50% forced vital capacity; $\dot{\text{V}}$₂₅, flow at 25% forced vital capacity.

^*From 36 subjects aged ≥ 12 years; ^†From 51 subjects aged < 12 years.